Notice: All products are for laboratory research use only
1 published article in GLP-1 Safety Foundations
What is the difference between tirzepatide and retatrutide?
Tirzepatide is a dual GIP and GLP-1 receptor agonist with FDA-approved prescription uses. Retatrutide is an investigational triple agonist that also targets the glucagon receptor. Their mechanisms, evidence maturity, and regulatory status are different.
By PepMarket Editorial Team
